4.5 Article

Mediation of Reduced Hippocampal Volume by Cerebral Amyloid Angiopathy in Pathologically Confirmed Patients with Alzheimer's Disease

Related references

Note: Only part of the references are listed.
Review Clinical Neurology

Prevalence of cerebral amyloid angiopathy: A systematic review and meta-analysis

Lieke Jakel et al.

Summary: Reported prevalence estimates of sporadic cerebral amyloid angiopathy (CAA) vary widely, with differences observed in AD patients and the general population. The study found that CAA prevalence based on pathology is higher than that based on presence of strictly lobar cerebral microbleeds. Both methods yield similar estimated prevalences in cognitively normal elderly, patients with intracerebral hemorrhage, and patients with lobar intracerebral hemorrhage. However, large heterogeneity among neuropathology and MRI protocols calls for standardized assessment and reporting of CAA.

ALZHEIMERS & DEMENTIA (2022)

Article Clinical Neurology

The Boston criteria version 2.0 for cerebral amyloid angiopathy: a multicentre, retrospective, MRI-neuropathology diagnostic accuracy study

Andreas Charidimou et al.

Summary: This study aimed to update and validate the Boston criteria for the diagnosis of cerebral amyloid angiopathy (CAA). The results showed that the Boston criteria version 2.0 had superior accuracy in terms of sensitivity and specificity, and incorporated new MRI markers.

LANCET NEUROLOGY (2022)

Article Cell Biology

APOE immunotherapy reduces cerebral amyloid angiopathy and amyloid plaques while improving cerebrovascular function

Monica Xiong et al.

Summary: The study examined the therapeutic effects of the anti-human APOE antibody HAE-4 in reducing amyloid pathology and protecting cerebrovascular integrity. Compared to other anti-Aβ antibodies, HAE-4 did not induce microhemorrhages and improved the function of brain arteries.

SCIENCE TRANSLATIONAL MEDICINE (2021)

Article Neurosciences

Cortical Thickness and its Association with Clinical Cognitive and Neuroimaging Markers in Cerebral Amyloid Angiopathy

Arsenije Subotic et al.

Summary: This study found that global cortical thickness was lower in CAA patients compared to healthy controls, but slightly higher than in AD patients. In the AD signature region, cortical thickness in CAA was also lower compared to the healthy controls. Within the CAA group, lower cortical thickness was associated with lower memory scores and higher white matter hyperintensity volume.

JOURNAL OF ALZHEIMERS DISEASE (2021)

Review Clinical Neurology

Cerebral amyloid angiopathy and Alzheimer disease - one peptide, two pathways

Steven M. Greenberg et al.

NATURE REVIEWS NEUROLOGY (2020)

Article Clinical Neurology

Cognitive Correlates of Hippocampal Atrophy and Ventricular Enlargement in Adults with or without Mild Cognitive Impairment

Naira Goukasian et al.

DEMENTIA AND GERIATRIC COGNITIVE DISORDERS EXTRA (2019)

Article Clinical Neurology

The Revised National Alzheimer's Coordinating Center's Neuropathology Form-Available Data and New Analyses

Lilah M. Besser et al.

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2018)

Review Endocrinology & Metabolism

Ischemic brain injury in cerebral amyloid angiopathy

Yael D. Reijmer et al.

JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2016)

Article Clinical Neurology

Cortical atrophy in patients with cerebral amyloid angiopathy: a case-control study

Panagiotis Fotiadis et al.

LANCET NEUROLOGY (2016)

Article Clinical Neurology

Cerebral beta-Amyloid Angiopathy Is Associated with Earlier Dementia Onset in Alzheimer's Disease

Eric D. Vidoni et al.

NEURODEGENERATIVE DISEASES (2016)

Article Clinical Neurology

APOE associations with severe CAA-associated vasculopathic changes: collaborative meta-analysis

Kristiina Rannikmaee et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2014)

Review Clinical Neurology

Outcome markers for clinical trials in cerebral amyloid angiopathy

Steven M. Greenberg et al.

LANCET NEUROLOGY (2014)

Article Multidisciplinary Sciences

APOE ε4 Is Associated with Disproportionate Progressive Hippocampal Atrophy in AD

Emily N. Manning et al.

PLOS ONE (2014)

Article Cell Biology

Human apoE Isoforms Differentially Regulate Brain Amyloid-β Peptide Clearance

Joseph M. Castellano et al.

SCIENCE TRANSLATIONAL MEDICINE (2011)

Article Clinical Neurology

Brain Atrophy and Cerebral Small Vessel Disease A Prospective Follow-Up Study

Arani Nitkunan et al.

STROKE (2011)